Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis
Crossref DOI link: https://doi.org/10.1186/s13244-024-01706-8
Published Online: 2024-05-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cong, Lanqing
Deng, Yan
Cai, Shuo
Wang, Gongzheng
Zhao, Xinya
He, Jingzhen
Zhao, Songbo
Wang, Li http://orcid.org/0009-0003-7680-5331
Text and Data Mining valid from 2024-05-12
Version of Record valid from 2024-05-12
Article History
First Online: 12 May 2024